Anupam Rama
Stock Analyst at J.P. Morgan
(4.87)
# 352
Out of 5,040 analysts
793
Total ratings
50.2%
Success rate
22.3%
Average return
Main Sectors:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CCCC C4 Therapeutics | Initiated: Buy | $10 | $2.85 | +250.88% | 1 | Oct 9, 2026 | |
| ANAB AnaptysBio | Rated: Buy | $70 → $60 | $46.21 | +29.84% | 35 | Sep 30, 2026 | |
| ANNX Annexon | Rated: Buy | $14 → $15 | $4.00 | +275.00% | 22 | Sep 30, 2026 | |
| SRPT Sarepta Therapeutics | Rated: Hold | $20 | $18.21 | +9.83% | 66 | Sep 30, 2026 | |
| KOD Kodiak Sciences | Reiterated: Buy | n/a | $94.26 | - | 24 | Sep 28, 2026 | |
| CELC Celcuity | Initiated Coverage: Buy | $157 | $67.87 | +131.32% | 1 | Sep 17, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | n/a | $29.73 | - | 35 | Sep 15, 2026 | |
| AGMB AgomAb Therapeutics NV | Reiterated: Buy | n/a | $9.22 | - | 2 | Sep 14, 2026 | |
| OLMA Olema Pharmaceuticals | Reiterated: Buy | n/a | $7.82 | - | 32 | Sep 14, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $62 | $30.08 | +106.12% | 17 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $80 → $36 | $15.29 | +135.45% | 32 | Sep 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $15.46 | +113.45% | 14 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $24.81 | +45.10% | 23 | Sep 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 → $21 | $13.04 | +61.04% | 35 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $51 → $46 | $14.17 | +224.63% | 2 | Aug 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $65 | $32.01 | +103.06% | 4 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $2.47 | +345.34% | 14 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.66 | - | 6 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $100 → $111 | $65.04 | +70.66% | 43 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $6.82 | +61.29% | 17 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $40 | $16.90 | +136.69% | 25 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $62 | $36.06 | +71.94% | 38 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $217 | $141.25 | +53.63% | 66 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $12.03 | +91.19% | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $90 | $52.04 | +72.94% | 20 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $72 → $107 | $78.75 | +35.87% | 25 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $9 | $3.70 | +143.24% | 3 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $3.75 | - | 5 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $53 | $25.88 | +104.79% | 11 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1.37 | - | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $12.10 | +57.02% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $19.13 | +109.10% | 2 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $11.01 | -45.50% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.99 | n/a | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $204 → $170 | $224.53 | n/a | 14 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $2.49 | n/a | 11 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.365 | n/a | 11 | Nov 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $27 → $5 | $9.11 | n/a | 6 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $64 | $62.01 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 → $48 | $31.92 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $8 | $79.90 | n/a | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $51 → $45 | $139.91 | n/a | 6 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.78 | n/a | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $42.20 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $30 → $37 | $11.12 | n/a | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $0.000001 | n/a | 8 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $56 → $10 | $10.58 | n/a | 5 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $16.37 | n/a | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $1.53 | n/a | 2 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $48.72 | n/a | 9 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $62.56 | n/a | 10 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $193.73 | n/a | 1 | Sep 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $3.87 | n/a | 10 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $13.75 | n/a | 4 | Jun 15, 2016 |
C4 Therapeutics
Oct 9, 2026
Initiated: Buy
Price Target: $10
Current: $2.85
Upside: +250.88%
AnaptysBio
Sep 30, 2026
Rated: Buy
Price Target: $70 → $60
Current: $46.21
Upside: +29.84%
Annexon
Sep 30, 2026
Rated: Buy
Price Target: $14 → $15
Current: $4.00
Upside: +275.00%
Sarepta Therapeutics
Sep 30, 2026
Rated: Hold
Price Target: $20
Current: $18.21
Upside: +9.83%
Kodiak Sciences
Sep 28, 2026
Reiterated: Buy
Price Target: n/a
Current: $94.26
Upside: -
Celcuity
Sep 17, 2026
Initiated Coverage: Buy
Price Target: $157
Current: $67.87
Upside: +131.32%
Vera Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.73
Upside: -
AgomAb Therapeutics NV
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.22
Upside: -
Olema Pharmaceuticals
Sep 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.82
Upside: -
Cogent Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: $62
Current: $30.08
Upside: +106.12%
Sep 3, 2026
Downgraded: Hold
Price Target: $80 → $36
Current: $15.29
Upside: +135.45%
Sep 1, 2026
Reiterated: Buy
Price Target: $33
Current: $15.46
Upside: +113.45%
Sep 1, 2026
Reiterated: Buy
Price Target: $36
Current: $24.81
Upside: +45.10%
Aug 26, 2026
Rated: Buy
Price Target: $20 → $21
Current: $13.04
Upside: +61.04%
Aug 25, 2026
Rated: Buy
Price Target: $51 → $46
Current: $14.17
Upside: +224.63%
Aug 19, 2026
Reiterated: Buy
Price Target: $30 → $65
Current: $32.01
Upside: +103.06%
Aug 17, 2026
Reiterated: Buy
Price Target: $11
Current: $2.47
Upside: +345.34%
Aug 13, 2026
Reiterated: Hold
Price Target: n/a
Current: $1.66
Upside: -
Aug 12, 2026
Rated: Buy
Price Target: $100 → $111
Current: $65.04
Upside: +70.66%
Aug 11, 2026
Reiterated: Buy
Price Target: $11
Current: $6.82
Upside: +61.29%
Aug 11, 2026
Reiterated: Buy
Price Target: $45 → $40
Current: $16.90
Upside: +136.69%
Aug 10, 2026
Reiterated: Buy
Price Target: $66 → $62
Current: $36.06
Upside: +71.94%
Aug 6, 2026
Reiterated: Buy
Price Target: $217
Current: $141.25
Upside: +53.63%
Aug 6, 2026
Reiterated: Buy
Price Target: $23
Current: $12.03
Upside: +91.19%
Aug 6, 2026
Reiterated: Buy
Price Target: $53 → $90
Current: $52.04
Upside: +72.94%
Jul 29, 2026
Rated: Buy
Price Target: $72 → $107
Current: $78.75
Upside: +35.87%
Jun 22, 2026
Upgraded: Buy
Price Target: $9
Current: $3.70
Upside: +143.24%
Jun 2, 2026
Downgraded: Sell
Price Target: n/a
Current: $3.75
Upside: -
May 22, 2026
Reiterated: Buy
Price Target: $58 → $53
Current: $25.88
Upside: +104.79%
Mar 24, 2026
Reiterated: Sell
Price Target: n/a
Current: $1.37
Upside: -
Mar 3, 2026
Reiterated: Buy
Price Target: $19
Current: $12.10
Upside: +57.02%
Dec 18, 2025
Reiterated: Buy
Price Target: $40
Current: $19.13
Upside: +109.10%
Nov 18, 2025
Reiterated: Sell
Price Target: $6
Current: $11.01
Upside: -45.50%
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $16.99
Upside: n/a
Feb 1, 2024
Reiterated: Hold
Price Target: $204 → $170
Current: $224.53
Upside: n/a
Dec 22, 2023
Downgraded: Sell
Price Target: n/a
Current: $2.49
Upside: n/a
Nov 13, 2022
Downgraded: Sell
Price Target: n/a
Current: $0.365
Upside: n/a
Aug 15, 2022
Reiterated: Hold
Price Target: $27 → $5
Current: $9.11
Upside: n/a
May 11, 2022
Reiterated: Buy
Price Target: $55 → $64
Current: $62.01
Upside: n/a
May 10, 2022
Reiterated: Hold
Price Target: $50 → $48
Current: $31.92
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $9 → $8
Current: $79.90
Upside: n/a
May 6, 2022
Reiterated: Buy
Price Target: $51 → $45
Current: $139.91
Upside: n/a
Mar 8, 2022
Downgraded: Hold
Price Target: n/a
Current: $3.78
Upside: n/a
Nov 12, 2021
Reiterated: Buy
Price Target: $55
Current: $42.20
Upside: n/a
Oct 25, 2021
Upgraded: Hold
Price Target: $30 → $37
Current: $11.12
Upside: n/a
Aug 5, 2021
Upgraded: Buy
Price Target: $6
Current: $0.000001
Upside: n/a
Mar 25, 2021
Downgraded: Sell
Price Target: $56 → $10
Current: $10.58
Upside: n/a
Oct 12, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $16.37
Upside: n/a
Jun 5, 2019
Downgraded: Sell
Price Target: n/a
Current: $1.53
Upside: n/a
Mar 1, 2019
Reiterated: Buy
Price Target: $7 → $6
Current: $48.72
Upside: n/a
Nov 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $62.56
Upside: n/a
Sep 29, 2017
Reiterated: Hold
Price Target: n/a
Current: $193.73
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $20 → $19
Current: $3.87
Upside: n/a
Jun 15, 2016
Reiterated: Hold
Price Target: n/a
Current: $13.75
Upside: n/a